Lipopolysaccharide Mediates Endothelial Apoptosis by a FADD-dependent Pathway
Open Access
- 1 August 1998
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 273 (32) , 20185-20188
- https://doi.org/10.1074/jbc.273.32.20185
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- RAIDD is a new 'death' adaptor moleculeNature, 1997
- Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmACurrent Biology, 1996
- FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling ComplexCell, 1996
- Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell DeathCell, 1996
- A License to KillCell, 1996
- FADD/MORT1 Is a Common Mediator of CD95 (Fas/APO-1) and Tumor Necrosis Factor Receptor-induced ApoptosisJournal of Biological Chemistry, 1996
- The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activationCell, 1995
- HMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell LineJournal of Investigative Dermatology, 1992
- BIOCHEMISTRY OF ENDOTOXINSAnnual Review of Biochemistry, 1990
- Human endothelial cell response to lipopolysaccharide, interleukin-1, and tumor necrosis factor is regulated by protein synthesisCellular Immunology, 1989